- Home
- STKH vs APM Comparison
STKH vs APM Comparison
Compare STKH & APM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STKH
- APM
- Stock Information
- Founded
- STKH 2018
- APM 2010
- Country
- STKH Israel
- APM United Kingdom
- Employees
- STKH N/A
- APM N/A
- Industry
- STKH Packaged Foods
- APM Biotechnology: Pharmaceutical Preparations
- Sector
- STKH Consumer Staples
- APM Health Care
- Exchange
- STKH Nasdaq
- APM Nasdaq
- Market Cap
- STKH 4.6M
- APM 4.0M
- IPO Year
- STKH 2021
- APM 2018
- Fundamental
- Price
- STKH $1.52
- APM $0.74
- Analyst Decision
- STKH
- APM
- Analyst Count
- STKH 0
- APM 0
- Target Price
- STKH N/A
- APM N/A
- AVG Volume (30 Days)
- STKH 35.3K
- APM 69.7K
- Earning Date
- STKH 08-30-2024
- APM 12-27-2024
- Dividend Yield
- STKH N/A
- APM N/A
- EPS Growth
- STKH N/A
- APM N/A
- EPS
- STKH N/A
- APM N/A
- Revenue
- STKH N/A
- APM $431,378.00
- Revenue This Year
- STKH N/A
- APM $157,729.10
- Revenue Next Year
- STKH N/A
- APM N/A
- P/E Ratio
- STKH N/A
- APM N/A
- Revenue Growth
- STKH N/A
- APM N/A
- 52 Week Low
- STKH $1.47
- APM $0.46
- 52 Week High
- STKH $7.70
- APM $17.49
- Technical
- Relative Strength Index (RSI)
- STKH 22.37
- APM 41.12
- Support Level
- STKH $1.45
- APM $0.73
- Resistance Level
- STKH $1.82
- APM $0.78
- Average True Range (ATR)
- STKH 0.22
- APM 0.09
- MACD
- STKH -0.04
- APM 0.04
- Stochastic Oscillator
- STKH 6.00
- APM 64.47
About STKH Steakholder Foods Ltd.
Steakholder Foods Ltd is a deep-tech food company. The company is cultivating meat technologies to improve meat production, simplify the meat supply chain, and offer consumers a range of new product offerings. The company aims to provide an alternative to industrialized animal farming that reduces carbon footprint, minimizes water and land usage, and prevents the slaughtering of animals. It is developing a novel, proprietary three-dimensional bioprinter for three-dimensional printing of meat and seafood analogs, followed by hybrid meats that combine cultivated and plant-based elements.
About APM Aptorum Group Limited
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in two segments: Therapeutics and Non-Therapeutics. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.